ATELERIX LIMITED

10803595
Active North Shields

Research and experimental development on biotechnology

10 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

ATELERIX LIMITED

10803595

Research and experimental development on biotechnology

Founded 5 Jun 2017 Active North Shields, England 10 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 30 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 23 Jul 2025 Next due 6 Aug 2026 1 month remaining
Net assets £631K £514K 2024 year on year
Total assets £692K £474K 2024 year on year
Total Liabilities £61K £41K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Ye Olde Hundred Church Way North Shields NE29 0AE England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for ATELERIX LIMITED (10803595), an active life sciences and medical technology company based in North Shields, England. Incorporated 5 Jun 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type micro-entity
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

N/A

Net Assets

£630.96k

Increased by £514.42k (+441%)

Total Liabilities

£60.87k

Decreased by £40.91k (-40%)

Turnover

N/A

Employees

10

Decreased by 1 (-9%)

Debt Ratio

9%

Decreased by 38 (-81%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 6

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 3May 2019Seed
Investor 4May 2019Seed
Investor 5May 2019Seed

Share Capital

Share Capital

Share allotments and capital structure

20 Allotments 12,617,163 Shares £3.84m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
29 Mar 20262,359,534£525k£0.223
20 Dec 20241,460,674£325k£0.223
10 Sept 2024112,360£25k£0.223
22 Jul 20241,797,752£400k£0.223
25 Apr 202417,664£176.64£0.01

Officers

Officers

1 active 2 resigned
Status
Evans, Andrew Stephen, DrDirectorBritishUnited Kingdom5823 Feb 2024Active

Shareholders

Shareholders (74)

Mike Twinning
13.2%
1,512,940
Angel Cofund
8.8%
1,011,236

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Che John Connon

Ceased 26 Jan 2018

Ceased
Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Apr 2026OfficersAppointment of Dr Catherine Mary Elton as director on 4 Jun 2025
9 Apr 2026CapitalAllotment of shares (GBP 138.38256) on 29 Mar 2026
30 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
29 Sept 2025ResolutionResolutions
23 Jul 2025Confirmation StatementConfirmation statement made on 23 Jul 2025 with updates
9 Apr 2026 Officers

Appointment of Dr Catherine Mary Elton as director on 4 Jun 2025

9 Apr 2026 Capital

Allotment of shares (GBP 138.38256) on 29 Mar 2026

30 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

29 Sept 2025 Resolution

Resolutions

23 Jul 2025 Confirmation Statement

Confirmation statement made on 23 Jul 2025 with updates

Recent Activity

Latest Activity

Appointment of Dr Catherine Mary Elton as director on 4 Jun 2025

2 months ago on 9 Apr 2026

Allotment of shares (GBP 138.38256) on 29 Mar 2026

2 months ago on 9 Apr 2026

Annual accounts made up to 31 Dec 2024

8 months ago on 30 Sept 2025

Resolutions

8 months ago on 29 Sept 2025

Confirmation statement made on 23 Jul 2025 with updates

11 months ago on 23 Jul 2025